Medicine and Dentistry
Neoplasm
72%
Hypoxia
40%
Esophageal Adenocarcinoma
37%
Lung Cancer
33%
Esophagus
33%
Clinical Significance
33%
Stereotactic Body Radiation Therapy
33%
Molecular Imaging
33%
Nasopharynx Carcinoma
33%
Hepatocellular Carcinoma
33%
Neoadjuvant Chemotherapy
33%
Radioactive Tracer
33%
Surgical Margin
33%
Adenocarcinoma
33%
Xenograft
33%
Magnetic Resonance Imaging
33%
Biological Marker
33%
Trastuzumab
33%
Cisplatin
33%
Polyethylene Terephthalate
33%
Fluorodeoxyglucose F 18
20%
Treatment Response
13%
Prognostic Factor
13%
Fluorine-18
13%
Methionine
13%
Metastatic Carcinoma
13%
Positron Emission Tomography
13%
Monotherapy
13%
Angiogenesis
13%
Integrin
13%
Combination Therapy
13%
Odds Ratio
12%
Recurrent Disease
8%
Chemoradiotherapy
6%
Overall Survival
6%
Cell Proliferation
6%
Tumor Hypoxia
6%
Tumor Angiogenesis
6%
Sensitivity and Specificity
6%
Glucose Metabolism
6%
Endothelial Cell
6%
Tetraxetan
6%
Tumor Progression
6%
Positron Emission Tomography-Computed Tomography
6%
Head and Neck Cancer
6%
Neuroendocrine Tumor
6%
Carbon 11
6%
Clinical Study
6%
Radiation Therapy
6%
Vascular Bundle
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Polyethylene Terephthalate
66%
Fluorodeoxyglucose F 18
47%
Lung Cancer
40%
Tracer
33%
Non Small Cell Lung Cancer
33%
Solid Malignant Neoplasm
33%
Trastuzumab
33%
Cisplatin
33%
Esophageal Adenocarcinoma
33%
Biological Marker
33%
Chemoradiation Therapy
33%
Liver Cell Carcinoma
33%
Progression Free Survival
26%
Overall Survival
26%
Primary Tumor
20%
Combination Therapy
16%
Monotherapy
16%
Hypoxia
13%
Integrin
9%
Methionine
9%
Fluorine 18
9%
Malignant Neoplasm
9%
Clinical Trial
6%
Nursing and Health Professions
Esophageal Adenocarcinoma
41%
Neoplasm
34%
Adenocarcinoma
33%
Biological Marker
33%
Trastuzumab
33%
Xenograft
33%
Nuclear Magnetic Resonance Imaging
33%
Neoadjuvant Chemotherapy
33%
Cisplatin
33%
Relaxation Time
26%
Odds Ratio
25%
Confidence Interval
16%
Area under the Curve
16%
Recurrent Disease
16%
Tumor Volume
16%
Combination Therapy
13%
Monotherapy
13%
Malignant Neoplasm
8%
Imaging
8%
Bootstrapping
8%
Recurrence Risk
8%
Lymph Vessel Metastasis
8%
Diseases
8%
Tumor Differentiation
8%
Histogram
6%
Hypoxia
6%
Apparent Diffusion Coefficient
6%
